JGC
AGN

J. Goldman & Co’s Allergan plc AGN Stock Holding History

J. Goldman & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-9,100
Closed -$2.71M – 362
2015
Q1 		$2.71M Buy
9,100
+4,800
+112% +$1.37M 0.17% 158
2014
Q4 		$1.11M Sell
4,300
-4,300
-50% -$1.07M 0.13% 143
2014
Q3 		$2.08M Buy
+8,600
New +$1.92M 0.13% 178

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

J. Goldman & Co's AGN Position: Q2 2016 in Review

J. Goldman & Co sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 50,300 shares — an estimated $13.5M sold.

J. Goldman & Co first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $13.5M in Q1 2016. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • J. Goldman & Co reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • J. Goldman & Co sold 50,300 Allergan plc shares in Q2 2016, an estimated $13.5M.
  • J. Goldman & Co first reported a position in Allergan plc in Q2 2013 and held it in 6 quarters.
  • J. Goldman & Co's Allergan plc position peaked at $13.5M in Q1 2016.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on J. Goldman & Co's 13F filing for Q2 2016, filed 15 Aug 2016.